Home › Mantle Cell Lymphoma › Kentucky
Mantle Cell Lymphoma clinical trials in Kentucky
4 studies for Mantle Cell Lymphoma are looking for participants at sites in Kentucky.
Cities in Kentucky
Testing Continuous Versus Intermittent Treatment With the Study Drug Zanubrutinib for Older Patients With Previously Untreated Mantle Cell Lymphoma
- The James Graham Brown Cancer Center at University of Louisville, Louisville
- UofL Health Medical Center Northeast, Louisville
RecruitingPhase 3
Ages 60 and older · All sexes · Updated Oct 2, 2026 · NCT05976763Testing the Anti-cancer Drug, Glofitamab, in Patients With Mantle Cell Lymphoma (A Type of Blood Cancer) Whose Disease Returned After CAR-T Cell Therapy
- University of Kentucky/Markey Cancer Center, Lexington
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Sep 9, 2026 · NCT07003295A Study of ARC-02 in B-cell NHL
- Norton Cancer Institute, Louisville
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Aug 26, 2026 · NCT07691606The OPAL Study: AVM0703 for Treatment of Lymphoid Malignancies
- Norton Cancer Institute, Louisville
RecruitingPhase 1/2
Ages 12 to 95 · All sexes · Updated Apr 15, 2026 · NCT04329728From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.